1 – 5 of 5
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2017
-
Mark
Genome-wide, high-content siRNA screening identifies the Alzheimer’s genetic risk factor FERMT2 as a major modulator of APP metabolism
(
- Contribution to journal › Article
- 2015
-
Mark
Plasma amyloid-β and risk of Alzheimer's disease in the Framingham Heart Study.
(
- Contribution to journal › Article
- 2011
-
Mark
A large-scale genetic association study to evaluate the contribution of Omi/HtrA2 (PARK13) to Parkinson's disease
(
- Contribution to journal › Article
-
Mark
Independent and Joint Effects of the MAPT and SNCA Genes in Parkinson Disease
(
- Contribution to journal › Article
- 2010
-
Mark
Non-replication of association for six polymorphisms from meta-analysis of genome-wide association studies of Parkinson's disease : large-scale collaborative study
(
- Contribution to journal › Article